株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の携帯型健康管理・フィットネスセンサー市場の詳細動向

Global Mobile Health and Fitness Sensor Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 311625
出版日 ページ情報 英文 107 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界の携帯型健康管理・フィットネスセンサー市場の詳細動向 Global Mobile Health and Fitness Sensor Market 2014-2018
出版日: 2014年08月27日 ページ情報: 英文 107 Pages
概要

携帯型健康管理・フィットネスセンサーは、人体に関する様々な数値を計測するために健康管理/フィットネス機器で利用されています。センサー技術の急速かつ継続的な発達により、患者の規則的なモニタリングが可能となり、それが医療費の軽減や治療成果の改善などにつながっています。センサーは患者の健康関連データを収集して電子的記録を残すので、患者記録の効率的管理も可能となります。今後は、モバイル式の健康管理・フィットネスセンサーが家電製品に搭載され、それが健康管理・フィットネスセンサー市場全体の成長を促進するものと思われます。世界の携帯型健康管理・フィットネスセンサー市場の2013〜2018年の年平均成長率(CAGR)は40.29%にも達する、と推計されています。

当レポートでは、全世界の携帯型の健康管理・フィットネス用センサー市場について分析し、市場の概要や構造、市場規模の動向(今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 地域別の分析

  • 世界の携帯型健康管理・フィットネスセンサー市場:地域別の詳細動向(今後6年間分)

第8章 主要国市場

  • 米国

第9章 購入基準

第10章 市場の成長促進要因

第11章 促進要因とその影響力

第12章 市場の課題

第13章 促進要因・課題の影響力

第14章 市場の傾向

第15章 市場動向とその影響

第16章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
  • その他の著名なベンダー

第17章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 部門別の売上高
    • 地域別の売上高
    • 事業戦略
    • 近年の動向
    • 主要情報
    • SWOT分析
  • Acute Technology
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • 富士通
  • GE Healthcare
  • Honeywell International
  • LifeScan
  • Medtronic
  • オムロン
  • RF Technologies

第18章 その他の関連分析

図表一覧

目次
Product Code: IRTNTR4038

About Mobile Health and Fitness Sensors

A sensor measures physical quantity and converts raw data into observable data, which are used by various industries. Mobile health and fitness sensors are used in health and fitness devices to measure various body parameters. Rapid and continuous development in sensing technology can assist in regular patient monitoring. This would help in bringing down healthcare costs and provide improved treatment results. Sensors help in gathering patient health-related data and in the maintenance of electronic health records, which can reduce inefficiencies in patient record maintenance. Going forward, the use of mobile health and fitness sensors in consumer healthcare is expected to boost the Global Mobile Health and Fitness Sensor market.

TechNavio's analysts forecast the Global Mobile Health and Fitness Sensor market to grow at a CAGR of 40.29 percent over the period 2013-2018.

Covered in this Report

The Global Mobile Health and Fitness Sensor market covers the present scenario and the growth prospects for the period 2014-2018. To calculate market size, the report takes into account the unit shipments of health and fitness sensors used in wearable, implantable, and mobile health and fitness devices.

TechNavio's report, the Global Mobile Health and Fitness Sensor Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region, and the ROW; it also covers the Global Mobile Health and Fitness Sensor market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • APAC
  • Europe
  • North America
  • ROW

Key Vendors

  • Abbott Laboratories
  • Acute Technology
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • Fujitsu
  • GE Healthcare
  • Honeywell International
  • LifeScan
  • Medtronic
  • OMRON
  • RF Technologies

Other Prominent Vendors

  • Adidas
  • AgaMatrix
  • Analog Devices
  • Asahi Kasei Microdevices
  • Bosch Healthcare
  • Cardiocomm Solutions
  • Casio
  • Cellnovo
  • ChoiceMmed
  • Covidien
  • EM Microelectronic
  • Jawbone
  • Lifecomm
  • Philips
  • Qualcomm
  • ST Microelectronics
  • Texas Instruments
  • Zensorium

Market Driver

  • Increased Health Awareness

For a full, detailed list, view our report

Market Challenge

  • Lack of Standardization

For a full, detailed list, view our report

Market Trend

  • Rapid Growth in Combo Sensors

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will be the growth rate
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Geographical Segmentation

  • 07.1. Global Mobile Health and Fitness Sensor Market by Geographical Segmentation 2013 and 2018

08. Key Leading Countries

  • 08.1. US

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
  • 16.2. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Abbott Laboratories
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation by Revenue 2012
    • 17.1.4. Business Segmentation by Revenue 2011 and 2012
    • 17.1.5. Geographical Segmentation by Revenue 2012
    • 17.1.6. Business Strategy
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
  • 17.2. Acute Technology
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Product Segmentation
    • 17.2.4. Business Strategy
    • 17.2.5. SWOT Analysis
  • 17.3. Bayer HealthCare
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation by Revenue 2013
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Geographical Segmentation by Revenue 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Recent Developments
    • 17.3.8. SWOT Analysis
  • 17.4. F. Hoffmann-La Roche
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation by Revenue 2013
    • 17.4.4. Business Segmentation by Revenue 2012 and 2013
    • 17.4.5. Geographical Segmentation by Revenue 2013
    • 17.4.6. Business Strategy
    • 17.4.7. Recent Developments
    • 17.4.8. SWOT Analysis
  • 17.5. Fujitsu
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Geographical Segmentation by Revenue 2013
    • 17.5.6. Business Strategy
    • 17.5.7. Recent Developments
    • 17.5.8. SWOT Analysis
  • 17.6. GE Healthcare
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation
    • 17.6.4. Business Strategy
    • 17.6.5. Key Developments
    • 17.6.6. SWOT Analysis
  • 17.7. Honeywell International
    • 17.7.1. Key Facts
    • 17.7.2. Business Overview
    • 17.7.3. Business Segmentation by Revenue 2013
    • 17.7.4. Business Segmentation by Revenue 2012 and 2013
    • 17.7.5. Geographical Segmentation by Revenue 2013
    • 17.7.6. Business Strategy
    • 17.7.7. Recent Developments
    • 17.7.8. SWOT Analysis
  • 17.8. LifeScan
    • 17.8.1. Key Facts
    • 17.8.2. Business Overview
    • 17.8.3. Product Segmentation
    • 17.8.4. Geographical Segmentation by Revenue 2013
    • 17.8.5. Business Strategy
    • 17.8.6. Recent Developments
    • 17.8.7. SWOT Analysis
  • 17.9. Medtronic
    • 17.9.1. Key Facts
    • 17.9.2. Business Overview
    • 17.9.3. Business Segmentation by Revenue 2013
    • 17.9.4. Business Segmentation by Revenue 2012 and 2013
    • 17.9.5. Geographical Segmentation by Revenue 2013
    • 17.9.6. Business Strategy
    • 17.9.7. Recent Developments
    • 17.9.8. SWOT Analysis
  • 17.10. OMRON
    • 17.10.1. Key Facts
    • 17.10.2. Business Description
    • 17.10.3. Business Segmentation
    • 17.10.4. Business Strategy
    • 17.10.5. Revenue Segmentation by Business
    • 17.10.6. Revenue Comparison - 2012 and 2013
    • 17.10.7. Sales by Geographical Segmentation
    • 17.10.8. Key Developments
  • 17.11. SWOT Analysis
    • 17.11.1. SWOT Overview
  • 17.12. RF Technologies
    • 17.12.1. Key Facts
    • 17.12.2. Business Overview
    • 17.12.3. Business Segmentation
    • 17.12.4. Business Strategy
    • 17.12.5. Recent Developments
    • 17.12.6. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Mobile Health and Fitness Sensor Market Overview
  • Exhibit 3: Global Transparent Market 2013-2018 (units in million)
  • Exhibit 4: Global Mobile Health and Fitness Sensor Market by Geographical Segmentation 2013
  • Exhibit 5: Global Mobile Health and Fitness Sensor Market by Geographical Segmentation 2018
  • Exhibit 6: Global Diabetic Population Split by Geography in 2013
  • Exhibit 7: Average Life Expectancy of Major Countries in 2002 and 2012
  • Exhibit 8: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 9: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 10: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 11: Acute Technology: Product Segmentation 2013
  • Exhibit 12: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 13: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 14: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 15: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 16: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 17: F. Hoffmann-La Roche: Geographical Segmentation of Pharmaceuticals Division by Revenue 2013
  • Exhibit 18: F. Hoffmann-La Roche: Geographical Segmentation of Diagnostics Division by Revenue 2013
  • Exhibit 19: Fujitsu: Business Segmentation by Revenue 2013
  • Exhibit 20: Fujitsu: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 21: Fujitsu: Geographical Segmentation by Revenue 2013
  • Exhibit 22: GE Healthcare: Business Segmentation 2013
  • Exhibit 23: Honeywell International: Business Segmentation by Revenue 2013
  • Exhibit 24: Honeywell International: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 25: Honeywell International: Geographical Segmentation by Revenue 2013
  • Exhibit 26: LifeScan: Product Segmentation 2013
  • Exhibit 27: LifeScan: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 29: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 30: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 31: Business Segmentation of OMRON Corp.
  • Exhibit 32: Revenue Segmentation of OMRON Corp. (2013)
  • Exhibit 33: Revenue Comparison (US$ billion)
  • Exhibit 34: Revenue Segmentation of OMRON Corp. by Geography (2013)
  • Exhibit 35: RF Technologies: Business Segmentation 2013
Back to Top